Table of Contents Table of Contents
Previous Page  27 / 916 Next Page
Show Menu
Previous Page 27 / 916 Next Page
Page Background

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S8–S52



The NYMPHA-MD project: Next

generation mobile platforms for

health, in mental disorders

M. Faurholt-Jepsen

Rigshospitalet - Copenhagen university hospital, psychiatric center

Copenhagen, Copenhagen, Denmark

Bipolar Disorder is a common and complex mental disorder with

a prevalence of 1-2% and accounts as one of the most important

causes of disability at age 15-44 years worldwide.

Electronic versions of self-monitoring tools and symptom regis-

tration using computers, personal digital assistants (PDAs), text

messages, and web interfaces have been described in the litera-

ture and a large number of commercial Smartphone applications

for patients with bipolar disorder are available.

The Next Generation Mobile Platforms for Health, in Mental Dis-

orders project (the NYMPHA-MD project), funded by the European

Union’s Seventh Framework program for research, technological

development and demonstration, focuses on the implementation of

a Pre-Commercial Procurement of mobile e-health service for sup-

porting physicians and patients in the treatment of bipolar disorder

through continuous patients monitoring in order to dynamically

support illness management and potentially identify early warning


The NYMPHA-MD project will define the framework of a Pre-

Commercial Procurement for the provisioning of next generation

services advocated for mental health treatment with a special focus

on bipolar disorder based on the use of new technologies, open

standards and open platforms.

The NYMPHA-MD project will focus on identifying requirements

involved in the structuring of mental health services with a focus

on bipolar disorder treatment including medical, technological,

patients, legal, ethical, policy, risk management and business-

orientation needs in order to construct a reference model of service

provisioning useful in different European contexts.

Disclosure of interest

The author has not supplied his declaration

of competing interest.


Neuropersonaltrainer-mh: A new

computerized platform for the

cognitive remediation in

schizophrenia and bipolar disorders

N. Cardoner

1 ,

, A. Cebria


, C. Lopez-Sola


, M. Serra-Blasco



C. Massons


, V. Muriel


, G. Navarra


, E. Via


, J. Cobo



X. Golberg



Institut de Recerca Parc Taulí- I3PT, mental health, Sabadell, Spain


Consorci Hospitalari Parc Tauli-I3PT, mental health, Sabadell, Spain

Corresponding author.

Schizophrenia and mood disorders -including unipolar depression

and bipolar disorder-, are severe mental diseases with a highly

heterogeneous symptomatology, among which cognitive dysfunc-

tion has progressively emerged as a key cornerstone. Patients

suffering from these illnesses show significant deficits in differ-

ent neurocognitive and social cognition domains. These deficits are

evident during acute episodes, and in a high percentage of patients

persist in periods of recovery, playing a decisive role on functional

and clinical outcome. Nowadays, different pharmacological ther-

apies have been tested, obtaining non-conclusive results. In this

context, non-pharmacological strategies, such as neurocognitive

remediation, have emerged as promising therapeutic intervention.

Neurocognitive remediation comprises a program to rehabili-

tate cognitively impaired subjects, aiming either to restore their

cognitive functioning or to compensate them in specific cognitive

domains. One evolving approach, beginning to receive attention

for its initial promising results, is computerized cognitive training.

This technique employs tasks or games that exercise a particular

brain function which target specific neural networks in order to

improve cognitive functioning through neuroplasticity in a given

neural circuit. In this scenario, we report our recent results with



-MH; a module for neurocognitive reme-

diation consisting in a computerized telerehabilitation platform

that enables cognitive remediation programs to be carried out

in an intensive and personalized manner. Our group has applied



in a pilot study treating patients with early onset psy-

chotic disorder with positive and promising results, involving an

improvement in functionality, neurocognition, and social cognition

performance. Furthermore, new trials in bipolar disorder andmajor

depressive disorder have been recently started.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

Symposium: shame and guilt in clinical practice


Shame & guilt: Definitions,

antecedents and structure of


F. Oyebode

University of Birmingham, Birmingham, United Kingdom

Aims In this lecture I will define and distinguish between shame

and guilt. I will then discuss the potential causes of shame and guilt

and how these emotions manifest in behavioral and phenomenal

terms. I will conclude by introducing a classification that deals with

the varieties and nature of the pathologies of shame and guilt that

are evident in clinical practice. I will rely on concepts developed by

Karl Jaspers, Hans Jonas and Bernhard Schlink. In doing this I will be

exploring the role of moral and juridical principles upon the expe-

rience of shame and guilt including the place of the imperatives of

responsibility upon the experience of shame and guilt. I will argue

further that shame and guilt are as important as other secondary

emotions such as envy and jealousy but are not as examined and

studied in clinical practice. I will make a case for the centrality of

these emotions to an understanding of and response to particular

clinical conditions in daily practice.






Shame and Guilt are both important emotions that

are central to our understanding of and response to particular con-

ditions in daily practice. Their antecedents and structure provide a

basis for distinguishing between them.

Disclosure of interest

The author has not supplied his declaration

of competing interest.


Shame and guilt in mental disorders -

diagnostics and treatment

L. Madeira

Faculdade de medicina - universidade de lisboa, psychiatry, Lisbon,


Guilt and shame are important human emotions, which have been

studied by several different disciplines. Seminal and recent inputs

in Psychology (particularly Psychoanalysis) and Psychiatry are